1. Home
  2. Our Firm
  3. News
  4. Guggenheim Pledges 1% to Social Impact

Our Firm

July 26, 2015

Guggenheim Pledges 1% to Social Impact

NEW YORK – In May 2015, Guggenheim became one of the first financial services firms to pledge 1% of company equity, product and employee time to the communities in which we operate.

Launched by Atlassian, Entrepreneurs Foundation of Colorado and Salesforce Foundation in December 2014, Pledge 1% is a result of corporate social responsibility leaders coming together to encourage and challenge their peers to make a more meaningful impact in their communities. Other companies who have taken the pledge include Google, Yelp and Oracle.

By joining the Pledge 1% movement, Guggenheim seeks to not only deepen its commitment to social impact, but also to join a movement of corporate citizenship leaders and provide turnkey solutions that inspire, foster and celebrate early stage corporate philanthropy.

Learn more about Pledge 1% at www.pledge1percent.org.



November 09, 2020

Guggenheim Securities Hires David Levin to Expand Equity Capital Markets

NEW YORK, NY –  Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that David Levin will join the firm as a Senior Managing Director in Equity Capital Markets, focusing on providing clients with equity and equity-linked financing solutions through the public and alternative equity capital markets.

Read More

October 22, 2020

Guggenheim Securities Hires Joe Niemiec to Expand Middle Market Investment Banking Practice

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Joe Niemiec has joined the firm as a Senior Managing Director to expand its middle market investment banking coverage and to focus on advising companies in the services and industrials sectors.

Read More

October 05, 2020

Debjit Chattopadhyay Joins Guggenheim Securities as Senior Biotech Analyst

NEW YORK, NY – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Debjit Chattopadhyay will join the firm in December as a Managing Director and Senior Biotech Analyst as part of the Healthcare Equity Research team. Dr. Chattopadhyay’s research focus will be gene therapy and rare diseases.

Read More



© 2020 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.